Bio-Gene Technology Limited (ASX:BGT)
Australia · Delayed Price · Currency is AUD 0.0140
+0.0010 (7.69%)
Oct 30, 2026, 12:19 PM AEDT
Bio-Gene Technology Market Cap
Bio-Gene Technology has a market cap or net worth of 6.13 million as of October 29, 2026. It is the 45,722nd most valuable company in the world and the 1,487th biggest in Australia. Its market cap has decreased by 30.68% in one year.
Market Cap
6.13M
Enterprise Value
4.19M
Revenue
n/a
Global Rank
Country Rank
#1,487 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since November 29, 2017, Bio-Gene Technology's market cap has decreased from 20.89M to 6.13M, a decrease of -70.64%. That is a compound annual growth rate of -12.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 7.45M | 6.14% |
| Dec 29, 2025 | 7.02M | -18.97% |
| Dec 30, 2024 | 8.66M | -28.33% |
| Dec 29, 2023 | 12.08M | -32.09% |
| Dec 29, 2022 | 17.79M | -48.81% |
| Dec 31, 2021 | 34.76M | 61.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 12.91M |
| Cambium Bio | 12.36M |
| AdAlta | 9.64M |
| Invex Therapeutics | 7.52M |
| Zelira Therapeutics | 5.95M |
| Acrux | 5.90M |
| Tissue Repair | 5.74M |
| Biotron | 5.57M |